My past research focused on investigating the mechanisms by which mutant spliceosome factors, particularly SRSF2, deregulated RNA splicing and fueled oncogenesis in various leukemias. I have also assisted in the discovery of several chemical and shRNA inhibitors that exhibit significant therapeutic potential. While studying biology at Columbia, I aim to continue research in oncology and prepare myself for a medical profession.